Kate Fox Commercial Manager BCM Specials Ltd. Conditions of manufacture and supply of unlicensed medicinal products Bona fide unsolicited order Product.

Slides:



Advertisements
Similar presentations
Fundamentals of Pharmacology for Veterinary Technicians
Advertisements

Pharmacovigilance, the MHRA and Yellow Cards Aileen McKenna Senior Clinical Pharmacist.
Biopharmaceutical Quality
From POM to P From POM to P Wellard’s NHS training wellards.co.uk 2004.
National Clinical Homecare Association Carol Withenshaw Chair – NCHA Ltd January 15 th 2009.
10/05/ PDIG Award 2008/9: Purchasing for Safety – Injectable Medicines Dr Clare Crowley Lead Medicines Safety Pharmacist Oxford Radcliffe Hospitals.
EMIS Web Dispensing Overview from a Users perspective
GOOD PHARMACY PRACTICE
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Management of the Tuberculosis Drug Supply Module 13 – March 2010.
“SPECIALS” LEGAL BACKGROUND & INTRODUCTION TO GN14 Presented by Rob Lowe Director of Quality Assurance Specialist Services – East of England.
Community pharmacy. Actions of community pharmacists in society Procurement of medicines that are suitable for human consumption Storage of medicines.
Clinical Trials and Pharmacy
Unlicensed Medicines in Paediatrics Is there a problem ? Scottish Neonatal and Paediatric Pharmacist Group National Paediatric Pre- Registration Pharmacist.
Medico-legal aspects of “off-licence” prescribing in Obstetrics ENTER 2006 CONFERENCE Saj Shah Solicitor/Pharmacist 3 May 2006.
Pharmaceutical wholesaler Gergely ZAJZON MD Semmelweis University, EKK Egészségügyi Informatikai, Fejlesztő és Továbbképző Intézet.
© 2009 Michigan State University licensed under CC-BY-SA, original at Specifications.
Quality Management Legislation and private requirements.
HL7 Medication and UKCPRS Julie James Partner Blue Wave Informatics.
By J.Thitiri KEMRI-Wellcome Trust Research Programme Kilifi, Kenya PHARMACY AND PRODUCT ACCOUNTABILITY Version: 14-Nov-2009.
Unlicensed Medicinal Products - Under Scrutiny Mark Jackson Deputy Director QCNW Quality Control North West Education and Training Services.
Sub module 4 Drug Dispensing and Stock Management.
Pharmaceutical applications Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
THE UK EXPERIENCE RELATED TO CASE C- 185/10, COMMISSION v REPUBLIC OF POLAND DOES A “SPECIAL NEED” ARISE FOR AN UNLICENSED MEDICINE IF THE LICENSED EQUIVALENT.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. THE PRACTICE OF REGULATORY INTELLIGENCE: CASE STUDIES OMICS 5 th International Pharmaceutical.
VETERINARY PHARMACY Elizabeth Shipley.
Good Procurement Practices in National TB Programs
CD ROMs for Pharmaceutical use Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
ACCESS TO MEDICINES - POLICY AND ISSUES
Demonstrably Difficult to Compound Drug Products Kathleen Anderson, Pharm. D. Division of Prescription Drug Compliance and Surveillance Office of Compliance.
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
BNF for children and formulations Ian Costello British National Formulary.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
Healthcare Improvement Scotland is supporting clinical engagement with NHS board Area Drug and Therapeutics Committees (ADTCs) to develop collaborative.
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
Compounding Kenneth Schell Pharm. D President, CA State Board of Pharmacy.
1.  Chapter 8 covers pages  Objective  Explain need for compounding  Know equipment needed for compounding  Know techniques for compounding.
Medicines Act 1981 Medicines regulations 1984 Human medicines.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
Chapter 6 Dispensing Medications in the Community Pharmacy.
Radiopharmaceutical Production
RESTICTED DRUGS Risk Evaluation and Mitigation Strategies--REMS
October 28, F OOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 (FDAAA) and Risk Evaluation and Mitigation Strategies (REMS) Presented to the Ninth.
The Pharmaceutical Agent Order. Prescription An oral or written record of a physician ’ s order to pharmacist to dispense medication to patient. who can.
R EGULATING THE IMPORTATION & USE OF MEDICAL DEVICES.
Medicines Purchasing in Secondary Care in the NHS & the Market for Specials and Outsourced Services Kevan Wind, Medicines Procurement Specialist Pharmacist,
Clinical Pharmaceutical Science
Buying and Selling Specials in 2012 What the NHS customer wants How the contracting process helps them to get it Jane Page Principal Pharmacist Medicines.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast The Challenge: Tendering for Unlicensed.
QUALITY ASSURANCE OF PHARMACEUTICAL PRODUCTS IN RMH
Gill Butler NW Pharmacist Trainers Steering Group
Using Medicines Safely (2:50)
TRACEABILITY REQUIREMENTS UNDER EU GENERAL FOOD LAW
Packaging After compounding packaging of prescription should be done.
Pharmacy department, University hospital of North Staffordshire
HL7 Medication and UKCPRS
First Article Inspection
Pharmacy Francis Dowling – Senior Trials Coordinator
Using Medicines Safely (2:50)
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Prequalification of HIV/AIDS products and manufacturers
Compounded Drugs and Lack of Premarket FDA-Approval
Prescribing in Practice Part 1 (b)
Considering Monitored Dosage Systems?
Hospital pharmacy.
Radiopharmaceutical Production
Presentation transcript:

Kate Fox Commercial Manager BCM Specials Ltd

Conditions of manufacture and supply of unlicensed medicinal products Bona fide unsolicited order Product formulated to the requirement of the prescriber and is used for their individual patients on their direct responsibility Special manufacturer must hold MHRA Manufacturers Specials License A special may not be advertised or supplied if an equivalent licensed product is available Essential records must be kept and serious adverse drug reactions reported to the MHRA

Unlicensed imported Medicine Product with a license in its country of origin A non UK made unlicensed medicine or food supplement Special Manufacture Manufactured under a Specials License issued by the MHRA Manufactured under the Medicines Act Section 10 – by a pharmacy itself or a supplier known as extemporaneous dispensing

UK Licensed Medicine Off Label Use of UK Licensed Medicine Imported Product Licensed in the Country of Origin UK Manufactured Special made under an MHRA Specials License An extemporaneously dispensed medicine (under section 10) An Imported Product not licensed in the country of origin A non-UK made unlicensed medicine or food supplement

Licensed Medicine Used in compliance with the license and SPC then manufacturer assumes responsibility Unlicensed Medicine No SPC so prescriber takes full responsibility in law for any adverse effect caused by the medicine unless if can be demonstrated that the medicine was faulty

Pharmacy who orders the medicine has a responsibility to ensure Medicine supplied meets prescribers requirements Medicine is fit for patient use Responsible for formulation, bioavailability and stability of product Record keeping – correct documentation supplied with product

Any person supplying unlicensed medicines must keep the following records for 5 years Source of the special – manufacturer /supplier Quantity and date which supplied Patient details Batch Number C of A / C of C (manufactured special only) Details of any adverse drug reaction

Unlicensed Imports Translated PIL Over Label Manufactured Specials Batched Manufactured Specials – Certificate of Analysis Bespoke Manufactured Specials – Certificate of Conformity

MHRA Review of Unlicensed Medicines introduced over label of imported medicines as standard (not legal requirement) NHS Tenders Driving quality assurance for trusts Reducing work loads for trusts / suppliers Ensuring value for money for the NHS

Any Questions ?